Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study.
COVID-19, Novel coronavirus disease
CRP, C-reactive protein
Crohn's disease
Healthcare worker
IBD, inflammatory bowel disease
Inflammatory bowel disease
SARS-CoV-2
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2
TNF, tumor necrosis factor-alpha
UC, ulcerative colitis
Ulcerative colitis
Journal
Infection prevention in practice
ISSN: 2590-0889
Titre abrégé: Infect Prev Pract
Pays: England
ID NLM: 101777928
Informations de publication
Date de publication:
Mar 2023
Mar 2023
Historique:
received:
10
10
2022
accepted:
06
12
2022
pubmed:
6
1
2023
medline:
6
1
2023
entrez:
5
1
2023
Statut:
ppublish
Résumé
Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is unknown. To assess the risk of COVID-19 in healthcare workers with IBD. A case control study enrolled 326 healthcare workers with IBD from 17 GETAID centres and matched non-healthcare workers with IBD controls (1:1) for gender, age, disease subtype and year of diagnosis. The study period was year 2020 during the COVID-19 outbreak. In total, 59 COVID-19 were recorded among cases (n = 32) and controls (n = 27), including 2 severe COVID-19 (requiring hospitalization, mechanic ventilation) but no death. No difference was observed between healthcare workers and controls regarding the overall incidence rates of COVID-19 4.9 ± 2.2 Healthcare workers with IBD do not have an increased risk of COVID-19 compared with other patients with IBD.
Sections du résumé
Background
UNASSIGNED
Whether healthcare workers with inflammatory bowel disease (IBD) are at increased risk of Novel coronavirus disease (COVID-19) due to occupational exposure is unknown.
Aim
UNASSIGNED
To assess the risk of COVID-19 in healthcare workers with IBD.
Methods
UNASSIGNED
A case control study enrolled 326 healthcare workers with IBD from 17 GETAID centres and matched non-healthcare workers with IBD controls (1:1) for gender, age, disease subtype and year of diagnosis. The study period was year 2020 during the COVID-19 outbreak.
Results
UNASSIGNED
In total, 59 COVID-19 were recorded among cases (n = 32) and controls (n = 27), including 2 severe COVID-19 (requiring hospitalization, mechanic ventilation) but no death. No difference was observed between healthcare workers and controls regarding the overall incidence rates of COVID-19 4.9 ± 2.2
Conclusion
UNASSIGNED
Healthcare workers with IBD do not have an increased risk of COVID-19 compared with other patients with IBD.
Identifiants
pubmed: 36601289
doi: 10.1016/j.infpip.2022.100267
pii: S2590-0889(22)00068-3
pmc: PMC9800326
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100267Informations de copyright
© 2022 The Authors.
Références
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Clin Infect Dis. 2021 Jun 1;72(11):e695-e703
pubmed: 32945846
BMC Infect Dis. 2017 Aug 9;17(1):553
pubmed: 28793861
Dig Dis Sci. 2015 Aug;60(8):2436-45
pubmed: 25799938
Horm Metab Res. 2021 Feb;53(2):85-93
pubmed: 33395706
Gastroenterology. 2020 Jul;159(1):6-13.e6
pubmed: 32272113
N Engl J Med. 2021 Jul 29;385(5):406-415
pubmed: 34133856
J Infect Public Health. 2020 Jun;13(6):843-848
pubmed: 32493671
Gut. 2010 Oct;59(10):1363-8
pubmed: 20587545
Gastroenterology. 2006 Mar;130(3):650-6
pubmed: 16530505
Aliment Pharmacol Ther. 2018 Oct;48(7):713-722
pubmed: 30069921
J Hosp Infect. 2021 Jan;107:108-110
pubmed: 33137443
Am J Epidemiol. 2021 Jan 4;190(1):161-175
pubmed: 32870978
Mol Med Rep. 2020 Jul;22(1):9-19
pubmed: 32377709
J Crohns Colitis. 2014 Jun;8(6):443-68
pubmed: 24613021
Influenza Other Respir Viruses. 2019 Jan;13(1):3-9
pubmed: 30515985
Obesity (Silver Spring). 2020 Dec;28(12):2282-2289
pubmed: 32815621
Inflamm Bowel Dis. 2022 Aug 1;28(8):1265-1279
pubmed: 34718595
RMD Open. 2021 Oct;7(3):
pubmed: 34725262
Int J Colorectal Dis. 2015 Feb;30(2):237-42
pubmed: 25392256
Arch Cardiovasc Dis. 2021 May;114(5):352-363
pubmed: 34154953